Clinical Research Directory
Browse clinical research sites, groups, and studies.
PCOS Immune Function Predicts Metformin Efficacy
Sponsor: Shanghai 10th People's Hospital
Summary
In this study, the investigators will include PCOS patients who meet the trial criteria, introduce participants to the content of this study, and invite participants to participate. The immune function of peripheral blood samples of PCOS patients was detected by flow cytometry. Participants were further treated with metformin for 6 months and followed up after the intervention. The objective of this study was to investigate immune markers related to the efficacy of metformin in PCOS patients and to predict the efficacy of metformin in PCOS patients using immune function.
Official title: Prediction of Immune Status on the Efficacy of Metformin in the Treatment of Polycystic Ovary Syndrome
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-03-16
Completion Date
2026-07-01
Last Updated
2024-03-22
Healthy Volunteers
No
Interventions
Metformin
Take metformin for six months.
Locations (1)
Department of Endocrinology, Shanghai Tenth People's Hospital
Shanghai, China